Bristol-Myers Squibb Co  

(Public, NYSE:BMY)   Watch this stock  
Find more results for BMY
-0.19 (-0.28%)
Nov 27 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 67.81 - 68.44
52 week 51.82 - 70.54
Open 68.08
Vol / Avg. 1.39M/5.59M
Mkt cap 113.19B
P/E 64.16
Div/yield 0.37/2.18
EPS 1.06
Shares 1.67B
Beta 0.48
Inst. own 74%
Jan 25, 2016
Q4 2015 Bristol-Myers Squibb Co Earnings Release (Estimated) - 9:30AM EST - Add to calendar
Nov 10, 2015
Bristol-Myers Squibb Co at Credit Suisse Healthcare Conference
Nov 2, 2015
Bristol-Myers Squibb Co at �EBD BIO Europe- Fall
Oct 27, 2015
Q3 2015 Bristol-Myers Squibb Co Earnings Call
Oct 27, 2015
Q3 2015 Bristol-Myers Squibb Co Earnings Release
Oct 1, 2015
Bristol-Myers Squibb Co at Leerink Partners Immuno-Oncology Roundtable
Sep 17, 2015
Bristol-Myers Squibb Co at Morgan Stanley Healthcare Conference
Sep 8, 2015
Bristol-Myers Squibb Co to Discuss World Conference on Lung Cancer (WCLC) Highlights
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '15) 2014
Net profit margin 17.94% 12.78%
Operating margin 19.24% 11.41%
EBITD margin - 28.60%
Return on average assets 9.19% 5.61%
Return on average equity 18.75% 13.36%
Employees 25,000 -
CDP Score - 98 B


NEW YORK, NY 10154
United States - Map
+1-212-5464000 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
About Company - Wikipedia


Bristol-Myers Squibb Company (BMS) is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products across the world. The Company's products are sold to wholesalers, retail pharmacies, hospitals, government entities and the medical profession. The Company manufactures its products in the United States, Puerto Rico and in six foreign countries. The Company promotes the use of its products directly to healthcare professionals and providers, such as doctors, nurse practitioners, physician assistants, pharmacists, technologists, hospitals, Pharmacy Benefit Managers (PBMs) and Managed Care Organizations (MCOs). It also provides information about the use of its products to consumers in the United States through direct-to-consumer print, radio, television, and digital advertising and promotion. In addition, the Company holds rights to F001287, which is a preclinical, small-molecule IDO1-inhibitor.

Officers and directors

Giovanni Caforio M.D. Chief Executive Officer, Director
Age: 50
Bio & Compensation  - Reuters
Charles A. Bancroft Chief Financial Officer, Executive Vice President
Age: 55
Bio & Compensation  - Reuters
Louis S Schmukler President - Global Manufacturing and Supply
Age: 59
Bio & Compensation  - Reuters
Francis M. Cuss Executive Vice President, Chief Scientific Officer
Age: 60
Bio & Compensation  - Reuters
Sandra Leung Executive Vice President, General Counsel and Corporate Secretary
Age: 54
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Paul von Autenried Senior Vice President - Enterprise Services, Chief Information Officer
Age: 53
Bio & Compensation  - Reuters
Anne Nielsen Senior Vice President, Chief Compliance and Ethics Officer
Age: 54
Bio & Compensation  - Reuters
Joseph C. Caldarella Senior Vice President, Corporate Controller
Age: 59
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Ann Powell Judge Senior Vice President - Global Human Resources
Age: 49
Bio & Compensation  - Reuters
John E. Elicker Senior Vice President - Public Affairs
Age: 55
Bio & Compensation  - Reuters